Ginger J. Tsai

Ginger J. Tsai

Auto-generated profile, based on publicly available information

Ginger J. Tsai

Department of Laboratory Medicine, University of Washington, Seattle, Washington

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
MRMaegan E. Roberts
Maegan E. Roberts
JRJohn Michael O. Ranola
John Michael O. Ranola
MMMegan L. Marshall
Megan L. Marshall
LSLisa R. Susswein
Lisa R. Susswein
SGSara Graceffo
Sara Graceffo
BSBrian H. Shirts
Brian H. Shirts
The CDH1 gene (OMIM:192090) encodes the protein E-cadherin, a cell-to-cell adhesion molecule.1 Hereditary diffuse gastric cancer (HDGC) syndrome is caused by germline pathogenic variants in the CDH1 gene and is characterized by an increased risk for diffuse gastric cancer (DGC) and lobular breast cancer (LBC).2 Clinical testing criteria and medical management recommendations for HDGC were first established and published in 1999 by the International Gastric Cancer Linkage Consortium (IGCLC), a multidisciplinary collaboration of international clinical geneticists, gastroenterologists, surgeons, oncologists, pathologists, and molecular biologists.3 Revisions to the initial criteria were subsequently published in 2010 and 2015 (Table 1).2,4 Recent evaluation of the revised 2015 IGCLC clinical testing criteria in a laboratory-based CDH1 pathogenic variant cohort found that 65% of all individuals with pathogenic variants did not meet criteria.5 In addition, it has been suggested that CDH1 pathogenic variants may be present in women presenting with lobular breast cancer and no family history of gastric cancer.6,7 International Gastric Cancer Linkage Consortium criteria were developed to define a clinical syndrome and facilitate identification of risk genes rather than to determine risk in all individuals with a genetically defined syndrome. These observations suggest that criteria for clinical HDGC and genetic CDH1 syndromes may need to be separated.

30 October 2018 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
GTGinger J. Tsai
Ginger J. Tsai
JRJohn Michael O. Rañola
John Michael O. Rañola
CSChristina Smith
Christina Smith
LGLauren Thomas Garrett
Lauren Thomas Garrett
TBTimothy Bergquist Bs
Timothy Bergquist Bs
BSBrian H. Shirts
Brian H. Shirts

11 July 2019 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
JRJohn Michael O. Ranola
John Michael O. Ranola
GTGinger J. Tsai
Ginger J. Tsai
BSBrian H. Shirts
Brian H. Shirts

2 March 2017 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
PDF file
GTGinger J. Tsai
Ginger J. Tsai
CCCarrie A. Cameron
Carrie A. Cameron
JCJennifer L. Czerwinski
Jennifer L. Czerwinski
HMHector Mendez‐Figueroa
Hector Mendez‐Figueroa
SPSusan K. Peterson
Susan K. Peterson
SNSarah Jane Noblin
Sarah Jane Noblin

31 December 2018 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
PDF file
GTGinger J. Tsai
Ginger J. Tsai
LGLauren Thomas Garrett
Lauren Thomas Garrett
SMSukh Makhnoon
Sukh Makhnoon
DBDeborah J. Bowen
Deborah J. Bowen
WBWylie Burke
Wylie Burke
BSBrian H. Shirts
Brian H. Shirts

9 January 2020 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
PDF file
GTGinger J. Tsai
Ginger J. Tsai
ACAnnie T. Chen
Annie T. Chen
LGLauren T. Garrett
Lauren T. Garrett
WBWylie Burke
Wylie Burke
DBDeborah J. Bowen
Deborah J. Bowen
BSBrian H. Shirts
Brian H. Shirts